NCT02372266

Safety and Cost-Effectiveness of Early Maternal Newborn Infant Discharge

A Randomized Controlled Trial to Assess the Safety and Cost-Effectiveness of Early Maternal Newborn Infant Discharge

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 2,223 (actual)
• Sponsor: 59th Medical Wing · Federal
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

To determine the effect of a policy of early maternal-newborn infant discharge (12-24 hours) with a home visit on admission to the Level II/III nursery and hospital admissions and readmissions.

Detailed description

This is a randomized controlled trial designed to assess the safety of a policy of early maternal newborn infant discharge compared to a policy of routine discharge 2 to 3 days after delivery. The primary outcome is newborn admissions to the Level II or Level III neonatal care unit or hospital within three days of delivery. Secondary outcomes included admissions and readmissions at 2 weeks, 6 weeks and 6 months following delivery, maternal satisfaction with length of stay and overall birthing experience, lactation continuation rates, maternal anxiety, depression, confidence and family functioning. We applied the American Academy of Pediatrics criteria for early newborn discharge, but planned the analysis by intention to treat.

Conditions

• Pregnancy

Interventions

Type	Name	Description
OTHER	Early Maternal-Newborn Infant Discharge	Discharge from the hospital between 12-24 hours of life
OTHER	Routine discharge	Discharge of the mother and newborn 2 to 3 days after delivery

Timeline

• Start date: 1997-04-01
• Primary completion: 2001-01-01
• Completion: 2001-08-01
• First posted: 2015-02-26
• Last updated: 2015-02-26